HAE Stock-Based Compensation
Haemonetics Corp · Stock-Based Compensation
HAE Stock-Based Compensation
Latest reported$33.83Mperiod ending
HAE Stock-Based Comp ($0.00 → $33.83M)
Annual stock-based compensation
High-resolution chart · PNG
HAE stock-based compensation history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 33,827,000 | |
| 29,636,000 | |
| 28,332,000 | |
| 25,583,000 | |
| 24,359,000 | |
| 25,516,000 | |
| 20,454,000 | |
| 17,188,000 | |
| 13,025,000 | |
| 9,150,000 | |
| 6,949,000 | |
| 14,095,000 | |
| 13,081,000 | |
| 10,969,000 | |
| 9,286,000 | |
| 10,810,000 | |
| 10,267,000 | |
| 10,181,000 | |
| 0 | |
| 10,251,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |